These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25627875)

  • 1. The susceptibility of Campylobacter concisus to the bactericidal effects of normal human serum.
    Kirk KF; Nielsen HL; Nielsen H
    APMIS; 2015 Mar; 123(3):269-74. PubMed ID: 25627875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motility of Campylobacter concisus isolated from saliva, feces, and gut mucosal biopsies.
    Ovesen S; Kirk KF; Nielsen HL; Nielsen H
    APMIS; 2017 Mar; 125(3):230-235. PubMed ID: 28116789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of fecal calprotectin in Campylobacter concisus and Campylobacter jejuni/coli gastroenteritis.
    Nielsen HL; Engberg J; Ejlertsen T; Nielsen H
    Scand J Gastroenterol; 2013 May; 48(5):633-5. PubMed ID: 23448294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.
    Blaser MJ; Smith PF; Kohler PF
    J Infect Dis; 1985 Feb; 151(2):227-35. PubMed ID: 3968449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study.
    Nielsen HL; Ejlertsen T; Engberg J; Nielsen H
    Clin Microbiol Infect; 2013 May; 19(5):445-50. PubMed ID: 22512739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term and medium-term clinical outcomes of Campylobacter concisus infection.
    Nielsen HL; Engberg J; Ejlertsen T; Bücker R; Nielsen H
    Clin Microbiol Infect; 2012 Nov; 18(11):E459-65. PubMed ID: 22882347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome analysis of Campylobacter concisus strains from patients with inflammatory bowel disease and gastroenteritis provides new insights into pathogenicity.
    Chung HK; Tay A; Octavia S; Chen J; Liu F; Ma R; Lan R; Riordan SM; Grimm MC; Zhang L
    Sci Rep; 2016 Dec; 6():38442. PubMed ID: 27910936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of Campylobacter concisus infection in children.
    Nielsen HL; Engberg J; Ejlertsen T; Nielsen H
    Pediatr Infect Dis J; 2013 Nov; 32(11):1194-8. PubMed ID: 23743545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motility and biofilm formation of the emerging gastrointestinal pathogen Campylobacter concisus differs under microaerophilic and anaerobic environments.
    Ovesen S; Durack J; Kirk KF; Nielsen HL; Nielsen H; Lynch SV
    Gut Microbes; 2019; 10(1):34-44. PubMed ID: 30252590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology and comparative genomics of Campylobacter concisus strains from saliva, faeces and gut mucosal biopsies in inflammatory bowel disease.
    Kirk KF; Méric G; Nielsen HL; Pascoe B; Sheppard SK; Thorlacius-Ussing O; Nielsen H
    Sci Rep; 2018 Jan; 8(1):1902. PubMed ID: 29382867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campylobacter concisus pathotypes are present at significant levels in patients with gastroenteritis.
    Underwood AP; Kaakoush NO; Sodhi N; Merif J; Seah Lee W; Riordan SM; Rawlinson WD; Mitchell HM
    J Med Microbiol; 2016 Mar; 65(3):219-226. PubMed ID: 26698172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G response in patients with Campylobacter concisus diarrhea.
    Nielsen HL; Kaakoush NO; Mitchell HM; Nielsen H
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):151-4. PubMed ID: 26643061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Importance of
    Liu F; Ma R; Wang Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():243. PubMed ID: 30087857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive proteins of Campylobacter concisus, an emergent intestinal pathogen.
    Kovach Z; Kaakoush NO; Lamb S; Zhang L; Raftery MJ; Mitchell H
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):387-96. PubMed ID: 22092566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Campylobacter concisus as the etiologic agent of gastrointestinal diseases.
    Akutko K; Matusiewicz K
    Adv Clin Exp Med; 2017; 26(1):149-154. PubMed ID: 28397447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Campylobacter jejuni to strain-specific bactericidal activity in sera of infected patients.
    Pennie RA; Pearson RD; Barrett LJ; Lior H; Guerrant RL
    Infect Immun; 1986 Jun; 52(3):702-6. PubMed ID: 3710581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of inflammatory bowel disease after
    Nielsen HL; Dalager-Pedersen M; Nielsen H
    Scand J Gastroenterol; 2019 Mar; 54(3):265-272. PubMed ID: 30905214
    [No Abstract]   [Full Text] [Related]  

  • 18. Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data.
    Aabenhus R; On SL; Siemer BL; Permin H; Andersen LP
    J Clin Microbiol; 2005 Oct; 43(10):5091-6. PubMed ID: 16207968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomics of Campylobacter concisus: Analysis of clinical strains reveals genome diversity and pathogenic potential.
    Gemmell MR; Berry S; Mukhopadhya I; Hansen R; Nielsen HL; Bajaj-Elliott M; Nielsen H; Hold GL
    Emerg Microbes Infect; 2018 Jun; 7(1):116. PubMed ID: 29946138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovine campylobacterosis: preliminary studies of the efficacy of the in vitro serum bactericidal test as an assay for the potency of Campylobacter (Vibrio) fetus subsp intestinalis bacterins.
    Williams CE; Renshaw HW; Meinershagen WA; Everson DO; Chamberlain RK; Hall RF; Waldhalm DG
    Am J Vet Res; 1976 Apr; 37(4):409-15. PubMed ID: 1267237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.